197 INTERLEUKIN-10 PROTECTS AGAINST BLOOD-INDUCED JOINT DAMAGE  by Jansen, N.W. et al.
C116 Poster Presentations
197
INTERLEUKIN-10 PROTECTS AGAINST
BLOOD-INDUCED JOINT DAMAGE
N.W. Jansen1, J.A. Van Roon1, G. Roosendaal2,
M. Theobald2, J.W. Bijlsma1, F.P. Lafeber1
1Rheumatology & Clinical Immunology, University Medical
Center Utrecht, Utrecht, The Netherlands; 2Hematology/Van
Creveld Clinic, University Medical Center Utrecht, Utrecht, The
Netherlands
Purpose: Joint bleeds occur frequently in patients suffering from
haemophilia or can occur as a consequence of joint trauma
or major joint surgery. Even a limited number of bleeds has
been demonstrated to lead to severe joint damage in time.
Small amounts of IL-1 that are produced by activated mono-
cytes/macrophages as present within blood increase the pro-
duction of hydrogen peroxide (H2O2) by chondrocytes. The
hydrogen peroxide reacts with haemoglobin-derived iron from
damaged and phagocytosed red blood cells in the joint cavity,
which results in the formation of hydroxyl radicals in the vicinity
of chondrocytes. This leads to chondrocyte apoptosis and with
that the irreversible inhibition of cartilage matrix synthesis. This
primary cartilage-driven joint damage is followed by synovial
inﬂammation adding to joint damage. In search of possible inter-
ventions to prevent or limit the cartilage damaging effects of joint
bleeds, we evaluated the potential of IL-10.
Methods: Healthy human articular cartilage tissue explants were
cultured in the presence or absence of 50% v/v blood for 4 days,
followed by a recovery period of 12 days. IL-10 was added
in 0.1, 1 or 10 ng/ml. Also cartilage and synovium in case of
haemophilic arthropathy, obtained at joint replacement surgery,
were cultured in the presence of IL-10 (10 ng/ml). The effect on
cartilage matrix proteoglycan synthesis, -release, and -content
were determined as well as the IL-1β and TNFα production by
the synovium.
Results: IL-10 was able to prevent dose dependently the de-
crease in proteoglycan synthesis and the increase in proteo-
glycan release of cartilage exposed to blood (p<0.05). As a
consequence, the decrease in proteoglycan content after blood
exposure could be prevented dose dependently (p<0.05). With
10 ng/ml IL-10, which is still a low dose for local therapeutic treat-
ment, at least 50% reduction in adverse effects was observed
(p<0.05). The matrix turnover of haemophilic cartilage improved
upon addition of IL-10 and also the production of IL-1β and TNFα
by haemophilic synovium decreased in the presence of IL-10 (all
p<0.05).
Conclusions: The present results show that interleukin-10 pre-
vents the direct harmful effects of blood on articular cartilage and
has a beneﬁcial effect on the matrix turnover of haemophilic car-
tilage and pro-inﬂammatory cytokine production by haemophilic
synovium. Therefore, although treatment studies in addition to
prevention studies have to be performed; IL-10 might be worth-
while to test in clinical practice for local treatment of joint haem-
orrhages, to prevent joint damage in time.
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STRUCTURE AND TOPOLOGY OF ANK, A POLYTOPIC
TRANSMEMBRANE PROTEIN THAT REGULATES THE
TRANSPORT OF INORGANIC PYROPHOSPHATE
A.S. Dion, R. Zaka, C.J. Williams
Thomas Jefferson University, Philadelphia, PA
Purpose: These studies were designed to elucidate various
structural attributes of the multipass, transmembrane ANK pro-
tein for the purpose of understanding how it normally functions
in the transport of inorganic pyrophosphate, as well as to provide
relevant data for future projects aimed at determining how this
process is disrupted by disease-associated ANK mutations.
Methods: Initially, predictive algorithms were used extensively
for developing an ANK structural model. These included SignalP
to assess the probability that the hydrophobic N-terminal domain
might be cleaved by signal peptidase activity, and the prediction
of transmembrane (TM) domains by consensus. For the latter
analyses, a total of 11 algorithms were included in order to better
determine TM segment locations and their boundaries by the
application of a wider variety of selection criteria as compared to
employing a single predictive algorithm.
Eight peptides were synthesized (Sigma Genosys) on the ba-
sis of the ANK model and conjugated to KLH as immunogens
for generating rabbit antisera. Prior to use, each antiserum was
ammonium sulfate-precipitated and puriﬁed by immunoafﬁnity
chromatography using the cognate peptide bound to Afﬁ-Gel 10
or 15. These ANK peptide-speciﬁc antibodies were used for:
immunoblotting, localizing intracellular ANK expression in ﬁxed
ATDC5 and COS-7 cells by confocal microscopy (± perme-
abilization), and monitoring the effect(s) of endoglycosidase di-
gestion for determining endogenous ANK N-linked glycosylation
sites, as well as neo-glycosylation sites introduced into ANK by
site-directed mutagenesis (glycosylation scanning mutagenesis,
GSM).
Results: SignalP evaluation of the ﬁrst 60 residues of the ANK
sequence consistently demonstrated a negative outcome for a
signal peptidase cleavage site by the criteria of both the neural
network and the hidden Markov model algorithms. This predic-
tion is consonant with immunoblotting results that have shown
co-localization of binding for three antibody speciﬁcities repre-
senting the amino-terminus, the approximate sequence midpoint
and the carboxy-terminus. Therefore, the antigenic band at about
57 kDa represents the intact ANK sequence. The cellular local-
ization of the same peptide speciﬁcities were also examined
by confocal microscopy. In each instance, these epitopes dis-
played an intracellular localization; however, these results were
complicated by an apparent co-localization of ANK with cellular
organelles.
The model derived from consensus predictions indicates that
ANK is composed of 12 TMs with two of these being putative
(TMs 2 and 8). Models with 11 TMs, lacking either TM2 or TM8,
yielded structures and topologies that were incompatible with our
other results; however, a ten TM model, in which both TM2 and
TM8 were removed, was consistent. We have initiated studies
using GSM in order to resolve this issue.
Mouse and human ANK each have 3 triacceptor sites for N-linked
glycosylation; however, we have found that only the 347NVS site
has an attached oligosaccharide moiety, which established that
this site resides on an external loop. By contrast, the 317NPS
site is obviated by the prolyl residue and is part of an intracellular
loop so that access to the ER lumen is not possible. The latter
argument may also apply to the 461NES site that is situated on
a highly polar, internally disposed COOH-terminal domain.
Conclusions: ANK is a transmembrane glycoprotein with an
apparent molecular mass of approximately 57 kDa. To date, we
have assigned most of the loop topologies and have localized
the amino- and carboxy-termini as endofacial. These results are
consistent, at this time, with both a 10 or 12 TM model; GSM
studies are currently underway to clarify this point.
